ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Executive Director Appointed
|
|
Bluesky80
|
8 |
2.9K |
0 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
8
|
2.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Full Year Results
|
|
Bluesky80
|
7 |
3.2K |
1 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
7
|
3.2K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Response to ASX Aware Query
|
|
Bluesky80
|
26 |
8.8K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
26
|
8.8K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
3 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
395
|
164K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
2 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
395
|
164K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
1 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
395
|
164K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zenivol receives formal BfArM approval in Germany
|
|
Bluesky80
|
23 |
12K |
0 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
23
|
12K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zenivol receives formal BfArM approval in Germany
|
|
Bluesky80
|
23 |
12K |
0 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
23
|
12K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology License Agreement Update
|
|
Bluesky80
|
29 |
9.7K |
2 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
29
|
9.7K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
|
|
Bluesky80
|
7 |
3.6K |
4 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
7
|
3.6K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Hope 1 Longitudinal, Real-World Data Trial in ASD Results
|
|
Bluesky80
|
99 |
40K |
8 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
99
|
40K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Details of Investor Briefing Session
|
|
Bluesky80
|
10 |
3.3K |
4 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
10
|
3.3K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Details of Investor Briefing Session
|
|
Bluesky80
|
10 |
3.3K |
3 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
10
|
3.3K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Update - Consolidation/Split - ZLD
|
|
Bluesky80
|
43 |
25K |
3 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
43
|
25K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Update - Consolidation/Split - ZLD
|
|
Bluesky80
|
43 |
25K |
0 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
43
|
25K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
1 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
395
|
164K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
395
|
164K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
2 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
395
|
164K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
2 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
395
|
164K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
2 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
395
|
164K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
1 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
395
|
164K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira and Health House execute Scheme Implementation Deed
|
|
Bluesky80
|
8 |
4.7K |
1 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
8
|
4.7K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Bluesky80
|
12 |
5.7K |
0 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
12
|
5.7K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology Licence Agreement Update
|
|
Bluesky80
|
15 |
5.3K |
2 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
15
|
5.3K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology Licence Agreement Update
|
|
Bluesky80
|
15 |
5.3K |
1 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
15
|
5.3K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology Licence Agreement Update
|
|
Bluesky80
|
15 |
5.3K |
1 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
15
|
5.3K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology Licence Agreement Update
|
|
Bluesky80
|
15 |
5.3K |
2 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
15
|
5.3K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology Licence Agreement Update
|
|
Bluesky80
|
15 |
5.3K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
15
|
5.3K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Consolidation/Split - ZLD
|
|
Bluesky80
|
21 |
14K |
0 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
21
|
14K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Consolidation/Split - ZLD
|
|
Bluesky80
|
21 |
14K |
3 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
21
|
14K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Bluesky80
|
12 |
5.7K |
2 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
12
|
5.7K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Ceasing to be a substantial holder
|
|
Bluesky80
|
12 |
4.9K |
2 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
12
|
4.9K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
Bluesky80
|
48 |
17K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
48
|
17K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
Bluesky80
|
48 |
17K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
48
|
17K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
Bluesky80
|
48 |
17K |
3 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
48
|
17K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: December 2021 Quarterly Activities Report
|
|
Bluesky80
|
11 |
3.8K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
11
|
3.8K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: December 2021 Quarterly Activities Report
|
|
Bluesky80
|
11 |
3.8K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
11
|
3.8K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
0 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
395
|
164K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
1 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
395
|
164K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
5 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
395
|
164K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Bluesky80
|
395 |
164K |
2 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
395
|
164K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2021 Annual General Meeting Presentation
|
|
Bluesky80
|
8 |
2.9K |
1 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Letter to Shareholders
|
|
Bluesky80
|
4 |
2.0K |
0 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|